With five affiliated hospitals and patient care centers treating different patient populations, Dan L. Duncan Cancer Center members have access to an exceptionally strong patient base for clinical and translational research.
We continue to make valuable advancements into improved patient care through research, expediting the transfer of laboratory findings to bedside therapies. Our focus on conducting innovative clinical trials enables us to learn more about how drug therapies are working at a molecular level early on, so that we may more quickly apply new medications to benefit broader patient populations.
For our patients, participation in these clinical trials provides an opportunity to take part in the cancer discovery process while receiving expert medical care from investigators that rank among the leading specialists in their fields.
Clinical Trials Available
For a list of current cancer clinical trials available, please click here.
Clinical Research Resources
- Clinical Trials Support Unit (CTSU):
The CTSU provides operational support of clinical research to DLDCC members. The CTSU mission is to promote high-quality, regulatory-compliant clinical research by providing centralized management and oversight.
- Protocol Review and Monitoring Committee (PRMC)
Review, approval and monitoring of all cancer-related clinical research is a requirement of NCI-designated cancer centers. The PRMC serves this function for the DLDCC. Subject enrollment cannot begin until all proper regulatory approvals have been obtained, including both PRMC and IRB approvals.
- Data and Safety Monitoring (DSM)
DSM serves to ensure patient safety and to assist investigators with developing appropriate monitoring plans for their protocols.